Target intelligence / Profile preview

Lipopolysaccharide transport protein A (LptA)

Target
LptA
Molecular classification
Transporter, Periplasmic protein
01

Overview

Lipopolysaccharide transport protein A (LptA) is a periplasmic protein featuring a novel fold made up of 16 consecutive antiparallel beta-strands arranged in a twisted beta-jellyroll configuration. LptA participates as part of a bridge in the Lpt machinery, facilitating unidirectional movement of LPS molecules from the inner membrane to the outer membrane in Gram-negative bacteria. It assembles in a head-to-tail fashion to form fibers capable of shuttling LPS and interacts with other Lpt proteins (LptC and LptD) to ensure cell envelope integrity. Loss or mutation of LptA impairs LPS transport, sensitizing bacteria to environmental threats and antibiotics. LptA, together with other Lpt proteins (LptB-G), is indispensable for the survival of Gram-negative bacteria, making the Lpt transporter a highly attractive target for novel antibiotic development, especially amid rising multidrug resistance.

Other names
LptAlipopolysaccharide transport protein ALPS transport protein A
02

Mechanism of action

Drugs may inhibit LptA directly or trap LPS during transport, preventing proper cell envelope formation and increasing bacterial permeability

03

Biological functions

Maintenance of bacterial outer membrane integrityLipopolysaccharide (LPS) transport across the periplasmCell envelope biogenesis
04

Disease associations

InfectionAntibiotic resistance
05

Safety considerations

Specific safety concerns not documented for LptA as a drug target, but broad-spectrum targeting of bacterial Lpt system may impact microbiome balanceminimizing off-target effects and resistance is a challenge
06

Interacting drugs

Novel antibiotics that inhibit the Lpt complex have been described; for example, compound 1 can trap LPS in transit, disrupting membrane assembly

1 more in the full profile.

07

Biomarkers

LPS accumulationabnormal cell envelope structure

Beyond the preview

Go deeper on Lipopolysaccharide transport protein A (LptA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipopolysaccharide transport protein A (LptA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call